Association of Multiple Copies of the N-myc Oncogene with Rapid Progression of Neuroblastomas

New England Journal of Medicine

Volumn 313, Issue 18, 1985, Pages 1111-1116

  Seeger, Robert C ^a,b,c,d,e   Brodeur, Garrett M ^a,b,c,d,e   Sather, Harland ^a,b,c,d,e   Dalton, Andree ^a,b,c,d,e   Siegel, Stuart E ^a,b,c,d,e   Wong, Kwan Y ^a,b,c,d,e   Hammond, Denman ^a,b,c,d,e  

^a Children's Cancer Study Group ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MODEL; CANCER GROWTH; CHILD; DIAGNOSIS; ENDOCRINE SYSTEM; GENETIC ENGINEERING; HUMAN; NERVOUS SYSTEM; NEUROBLASTOMA; ONCOGENE; PRIORITY JOURNAL; SURVIVAL;

EID: 0022388606     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198510313131802     Document Type: Article

References (41)

1. Bishop JM. Cellular oncogenes and retroviruses. Annu Rev Biochem 1983; 52: 301–54.
2. Schwab M, Alitalo K, Klempnauer K-H, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983; 305: 245–8.
3. Kohl NE, Kanda N, Schreck RR, et al. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 1983; 35: 359–67.
4. Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE, Bishop JM, Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 1984; 81: 4940–4.
5. Kohl NE, Gee CE, Alt FW. Activated expression of the N-myc gene in human neuroblastomas and related tumors. Science 1984; 226: 1335–7.
6. Michitsch RW, Montgomery KT, Melera PW. Expression of the amplified domain in human neuroblastoma cells. Mol Cell Biol 1984; 4: 2370–80.
7. Schwab M, Varmus HE, Bishop JM. Human gene N-myc contributes to neoplastic transformation of mammalian cells in culture. Nature 1985; 316: 160–2.
8. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984; 224: 1121–4.
9. Evans AE, D'Angio GJ, Randolph JA. A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer 1971; 27: 374–8.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81.
11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–70.
12. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39.
13. Hill ID, Peto R. Probabilities derived from finite populations. Appl Stat 1971; 20: 99–105.
14. Evans AE. Staging and treatment of neuroblastoma. Cancer 1980; 45: 1799–802.
15. Evans AE, Albo V, D'Angio GJ, et al. Factors influencing survival of children with nonmetastatic neuroblastoma. Cancer 1976; 38: 661–6.
16. Breslow N, McCann B. Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 1971; 31: 2098–103.
17. Evans AE, Baum E, Chard R. Do infants with Stage IV-S neuroblastoma need treatment? Arch Dis Child 1981; 56: 271–4.
18. Reynolds CP, Frenkel EP, Smith RG. Growth characteristics of neuroblastoma in vitro correlate with patient survival. Trans Assoc Am Physicians 1980; 93: 203–17.
19. Thiele CJ, Reynolds CP, Israel MA. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 1985; 313: 404–6.
20. Johnson BE, Battey JF, Carney DC, Minna JD. Transfection of the c-myc proto-oncogene into classic small cell lung cancer (SCLC) cell lines causes phenotypic changes associated with c-myc amplified variant SCLC lines. Proc Am Assoc Cancer Res 1985; 26: 66. abstract.
21. Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. JNCI 1984; 73: 405–16.
22. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 1984; 311: 231–5.
23. Zeltzer PM, Marangos PJ, Parma AM, et al. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma: a report from the Children's Cancer Study Group. Lancet 1983; 2: 361–3.
24. Zeltzer PM, Marangos PJ, Sather H, et al. Prognostic importance Of serum neuron specific enolase in local and widespread neuroblastoma. In: Evans AE, D'Angio G, Seeger RC, eds. Advances in neuroblastoma research. New York: Alan R Liss, 1985:319–29.
25. Hann H-WL, Evans AE, Siegel SE, et al. Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: the Children's Cancer Study Group experience. Cancer Res 1985; 45: 2843–8.
26. Lee W-H, Murphee AL, Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 1984; 309: 458–60.
27. Collins S, Groudine M. Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature 1982; 298: 679–81.
28. Dalla Favera R, Wong-Staal F, Gallo RC. one Gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemia cells of the same patient. Nature 1982; 299: 61–3.
29. Nowell P, Finan J, Dalla Favera R, et al. Association of amplified oncogene c-myc with an abnormally banded chromosome 8 in a human leukemia cell line. Nature 1983; 306: 494–7.
30. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM. Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 1983; 80: 1707–11.
31. Kozbor D, Croce CM. Amplification of the C-myc oncogene in one of five human breast carcinoma cell lines. Cancer Res 1984; 44: 438–41.
32. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 1983; 306: 194–6.
33. Shibuya M, Yokota J, Ueyama Y. Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells. Mol Cell Biol 1985; 5: 414–8.
34. Pelicci P-G, Lanfrancone L, Brathwaite MD, Wolman SR, Dalla-Favera R. Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 1984; 224: 1117–21.
35. Alitalo K, Winqvist R, Lin CC, de la Chapelle A, Schwab M, Bishop JM, Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc Natl Acad Sci USA 1984; 81: 4534–8.
36. Collins SJ, Groudine MT. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc Natl Acad Sci USA 1983; 80: 4813–7.
37. Selden JR, Emanuel BS, Wang E, et al. Amplified Cλ and c-abl genes are on the same marker chromosome in K562 leukemia cells. Proc Natl Acad Sci USA 1983; 80: 7289–92.
38. Merlino GT, Xu Y, Ishii S, et al. Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science 1984; 224: 417–9.
39. Lin CR, Chen WS, Kruiger W, et al. Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science 1984; 224: 843–8.
40. Ullrich A, Coussens L, Hayflick JS, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984; 309: 418–25.
41. Liberman TA, Nusbaum HR, Razon N, et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 1985; 313: 144–7.